Introduction
COVID-19 has rapidly spread throughout the world in a very short period of time.1 By the end of 2022, 665 543 700 COVID-19 cases and 6 702 398 deaths due to COVID-19 were reported in multiple waves with the emergence of mutant variants, being second only to the 1918 Spanish influenza pandemic, despite the development of effective vaccines that were approved by WHO for emergency use.2 3 The morbidity and mortality due to COVID-19 infection are probably underestimates given that reporting and death registration systems in many countries are not 100% accurate and complete. In addition to causing a health burden, the COVID-19 pandemic has led to social and economic consequences throughout the world.
The mortality and development of complications from the diseases vary according to the age and presence of other comorbidities of affected individuals. Evidence shows that individuals who are older and having other comorbidities such as diabetes, cardiovascular diseases and chronic respiratory diseases are at increased risk of developing severe health consequences of COVID-19 infection.4 5
The health impact of COVID-19 has been investigated globally. The effects of the disease have been measured using mortality-based metrices such as case fatality rate, crude mortality rate and all-cause mortality. The number of deaths in a given region is never an accurate measure of mortality and does not reflect the true burden of the disease. To overcome this drawback, disability-adjusted life year (DALY) metric, developed by Murray and Lopez in 1994, is used instead. DALY is a composite measure which is calculated by taking the sum of two components: years of life lost (YLL) due to premature death and years lived with disability (YLDs).6 DALYs were originally used in the first Global Burden of Disease (GBD) study which quantified the health effects of >100 diseases for eight regions in the world in 1990.7 The advantage of using DALYs to measure disease burden is that it accounts for both mortality and morbidity associated with diseases which gives a more comprehensive assessment of the state of health in communities. However, the main disadvantage of DALYs is that they focus solely on health and do not capture the broader societal impact of diseases.8 Nevertheless, DALYs are commonly used to measure disease burden, and due to their wide usage, it enables comparison of disease burden between diseases, countries and different communities.
The first case of COVID-19 in Sri Lanka was detected on 27 January 2020 in a female tourist aged 44 years from Hubei province, China.9 The second case, which was also the first local case, was detected on 10 March 2020 in a tour guide aged 52 years who had recently been exposed to an Italian tour group.9 Sri Lanka was able to effectively curb the spread of the virus with rigorous measures for several months. However, during the first year of the pandemic, the epidemic spread originating from four clusters that were identified probably due to the gradual lessening of stringency measures with time to kick start a failing economy.
The Epidemiology Unit of the Ministry of Health, Sri Lanka maintains morbidity and mortality statistics related to COVID-19. The aim of this study was to estimate the DALYs related to COVID-19 pandemic in Sri Lanka from 27 January 2020 to 30 June 2022 including a component that accounts for the psychological stress that contacts may have experienced due to the stringent measures that were adopted during this time.